JPSIM Journal of Pakistan Society of Internal Medicine J Pak Soc Intern Med 2709-8729 2710-0804 Pakistan Society of Internal Medicine 10.70302/jpsim.v2i4.2179 jpsim.v2i4.2179 Medical Guidelines Recommendations for Diagnosis, Treatment & Monitoring of Chronic HCV Infection in Adults Hamid Saeed saeed.hamid@aku.edu * Hasnain Aliya Department of Medicine, Agha Khan University Karachi, Pakistan *Correspondence: Saeed Hamid (saeed.hamid@aku.edu) 14 12 2021 2021 2 4 349 355 18 08 2021 18 10 2021 Copyright © 2021 The Author(s) 2021 The Author(s) https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Objectives

Aim of present recommendations is to optimize Hepatitis C related patient care informed by best available evidence and broad consensus to improve clinical and public health outcomes. The aim is to provide recommendations that are relevant for the confined regional epidemiology of hepatitis C infection as well as healthcare delivery mechanism in Pakistan.

These recommendations are adapted from World Health Organization (WHO) guide for hepatitis C virus infection targeted particularly for low and middle income countries (LMICs), presenting high burden of disease while treatment is readily available and costs of direct-acting antivirals (DAAs) are on the decline.

 References World Health Organization. Hepatitis C Fact Sheet; WHO: Geneva, Switzerland, 2019 Blach S, Zeuzem S, Manns M, Altraif I, Duberg AS, Muljono DH, Waked I, Alavian SM, Lee MH, Negro F, Abaalkhail F. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol. 2017;2(3):161-76. Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N, et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 2000;284(4):450-6. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology. 1996;24(2):289-93. Sherman AC, Sherman KE. Extrahepatic manifestations of hepatitis C infection: navigating CHASM. Current Hiv/AIDS Reports. 2015;12(3):353-61. Franciscus A. HCV Transmission and Prevention–Hepatitis C Support Project. HCV Advocate. 2008 Mahmood H, Raja R. Risk factors of hepatitis C in Pakistan. Gastroenterol Hepatol Open Access. 2017;7(6):00259. Tang W, Chen W, Amini A, Boeras D, Falconer J, Kelly H, Peeling R, Varsaneux O, Tucker JD, Easterbrook P. Diagnostic accuracy of tests to detect Hepatitis C antibody: a meta-analysis and review of the literature. BMC infectious diseases. 2017 Nov;17(1):39-57. Shahid I, Alzahrani AR, Al-Ghamdi SS, Alanazi IM, Rehman S, Hassan S. Hepatitis C Diagnosis: Simplified Solutions, Predictive Barriers, and Future Promises. Diagnostics. 2021; 11(7):1253. Warkad SD, Nimse SB, Song KS, Kim T. HCV detection, discrimination, and genotyping technologies. Sensors. 2018 Oct;18(10):3423. Abid A, Uddin M, Muhammad T, Awan S, Applegate T, Dore GJ, Cloherty G, Hamid S. Evaluation of Hepatitis C Virus Core Antigen Assay in a Resource-Limited Setting in Pakistan. Diagnostics (Basel). 2021;11(8);1354. 10.3390/diagnostics11081354. Guidelines for the care and treatment of persons diagnosed with Chronic Hepatitis C virus infection, WHO 2018 Calès P, Oberti F, Michalak S, Hubert-Fouchard I, Rousselet MC, Konaté A, et.al. A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology. 2005;42(6):1373-81. Lin ZH, Xin YN, Dong QJ, Wang Q, Jiang XJ, Zhan SH, Sun Y, Xuan SY. Performance of the aspartate aminotransferase‐to‐platelet ratio index for the staging of hepatitis C‐related fibrosis: an updated meta‐analysis. Hepatology. 2011;53(3):726-36. Chou R, Wasson N. Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection: a systematic review. Ann Intern Med. 2013;158(11):807-20. Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et.al. APRICOT Clinical Investigators. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006;43(6):1317-25. Panackel C, Ganjoo N, Saif R, Jacob M. Decompensated Liver Disease: Liver Transplantation is the Best Option, Not the Last Option. Kerala Med J. 2016;9(1):11-27. Falade-Nwulia O, Suarez-Cuervo C, Nelson DR, Fried MW, Segal JB, Sulkowski MS. Oral direct-acting agent therapy for hepatitis C virus infection: a systematic review. Ann Intern Med. 2017;166(9):637–48.